HC Wainwright Comments on Nurix Therapeutics, Inc.’s FY2025 Earnings (NASDAQ:NRIX)
Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) – HC Wainwright issued their FY2025 earnings per share estimates for shares of Nurix Therapeutics in a note issued to investors on Tuesday, June 18th. HC Wainwright analyst R. Burns anticipates that the company will earn ($3.06) per share for the year. HC Wainwright has a “Buy” rating […]
More Stories
bioMérieux S.A. (OTCMKTS:BMXMF) Short Interest Update
bioMérieux S.A. (OTCMKTS:BMXMF – Get Free Report) was the target of a significant drop in short interest during the month...
Short Interest in Camden National Co. (NASDAQ:CAC) Expands By 31.5%
Camden National Co. (NASDAQ:CAC – Get Free Report) was the target of a significant increase in short interest during the...
Global X NASDAQ 100 Risk Managed Income ETF (NASDAQ:QRMI) Short Interest Up 48.8% in September
Global X NASDAQ 100 Risk Managed Income ETF (NASDAQ:QRMI – Get Free Report) saw a large growth in short interest...
Stronghold Digital Mining, Inc. (NASDAQ:SDIG) Short Interest Update
Stronghold Digital Mining, Inc. (NASDAQ:SDIG – Get Free Report) was the recipient of a significant decrease in short interest in...
Otsuka Holdings Co., Ltd. (OTCMKTS:OTSKY) Sees Large Increase in Short Interest
Otsuka Holdings Co., Ltd. (OTCMKTS:OTSKY – Get Free Report) saw a significant growth in short interest in September. As of...
BTCS Inc. (NASDAQ:BTCS) Short Interest Update
BTCS Inc. (NASDAQ:BTCS – Get Free Report) was the target of a large decline in short interest in September. As...